Zita-Met Plus 1000mg/20mg Tablet ER
By Zita-Met Plus
Rx
15 Tablet ER in a Strip

Composition
Metformin(1000mg) + Teneligliptin(20mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
March, 2026

liver
It is important to note that Zita-Met Plus 1000mg/20mg Tablet ER may not be safe for individuals with liver disease and should be avoided. It is recommended to consult with your doctor before using this medication to ensure your safety and appropriate treatment.

kidney
Zita-Met Plus 1000mg/20mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be necessary and it is not recommended in severe kidney disease. Regular kidney function test monitoring is advised during treatment. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Zita-Met Plus 1000mg/20mg Tablet ER. Avoid alcohol consumption during this medication. Consult your doctor about alcohol use with Zita-Met Plus 1000mg/20mg Tablet ER.

driving
It is uncertain if Zita-Met Plus 1000mg/20mg Tablet ER affects driving ability. Avoid driving if symptoms impact focus and reaction time.

pregnancy
Zita-Met Plus 1000mg/20mg Tablet ER may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for evaluation of benefits and risks before use.

breastfeeding
Caution Zita-Met Plus 1000mg/20mg Tablet ER is possibly unsafe during breastfeeding. Limited data shows the drug may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹315.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024